PBMs are again in the crosshairs of Congress and the FTC. This time, Congress is seeking ways to coordinate with the FTC to enact reforms. It’s becoming increasingly probable that some kind of action will be taken to create a more transparent drug pricing and rebate system.
Subscribe to:
Post Comments (Atom)
< + > Bonus Features – November 1, 2026 – 91% of patients want their permission required when AI is used for diagnosis, 64% of providers plan to deploy AI for claims and denials management, plus 20 more stories
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Announcement written by Zack Kanter, Founder and CEO at Stedi In February of last year, I gathered our engineering team in a war room. Chan...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
No comments:
Post a Comment